Hims & Hers Health Management
Management criteria checks 3/4
Hims & Hers Health's CEO is Andrew Dudum, appointed in Jan 2017, has a tenure of 7.25 years. total yearly compensation is $10.82M, comprised of 5.5% salary and 94.5% bonuses, including company stock and options. directly owns 9.22% of the company’s shares, worth $243.88M. The average tenure of the management team and the board of directors is 2.3 years and 3.1 years respectively.
Key information
Andrew Dudum
Chief executive officer
US$10.8m
Total compensation
| CEO salary percentage | 5.5% |
| CEO tenure | 7.3yrs |
| CEO ownership | 9.2% |
| Management average tenure | 2.3yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry
Apr 24Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation
Apr 05Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock
Mar 21Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health
Mar 12Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%
Feb 28
Hims & Hers: Turning The Profitability Corner And Returning 28%
Feb 25Hims & Hers Health: No Clear Moat Besides First Mover Advantage
Jan 23Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple
Jan 10Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)
Jan 07Hims & Hers Health Q3: The Cheapest Growth Stock Around
Dec 14Hims & Hers Health: What Would The Author Of 100 Baggers Say?
Nov 30Hims & Hers: The Most Undervalued Small Cap Stock I See
Nov 08Hims & Hers: A Promising Company With Resolvable Challenges
Nov 02Hims & Hers: Specialization Is The Secret To Great Growth
Oct 25Hims & Hers Health: Can't Get Much Better
Sep 25The Market Is Wrong On Hims & Hers Health
Sep 18Hims & Hers: The Current Weakness Creates A Buying Opportunity
Aug 15Hims & Hers Health: Giving Investors Another Bite At The Apple
Aug 01Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues
Jul 21Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong
Jul 13Hims & Hers Health: Double-Edged Sword
Jul 02Hims & Hers: More Transparency Could Help The Stock
Jun 09Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business
Apr 19Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?
Mar 30Him & Hers Health Q4 2022 Earnings Preview
Feb 24Hims & Hers spikes as Jefferies upgrades ahead of 2023 guidance
Feb 09Hims & Hers: Profitability Pulled Forward
Jan 25Hims & Hers Health: Buy Into The Strong Growth Momentum
Jan 18Devon Energy And Hims & Hers Health - Raul Shah's Hot Take
Jan 05Hims & Hers Health: The Ultimate Pick For 2023
Dec 23Hims & Hers Health: The Unicorn (Former) SPAC For 2023
Dec 17Hims & Hers Health Seems Like A Great Pick For 2023
Dec 10CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$24m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$47m |
| Mar 31 2023 | n/a | n/a | -US$59m |
| Dec 31 2022 | US$11m | US$600k | -US$66m |
| Sep 30 2022 | n/a | n/a | -US$86m |
| Jun 30 2022 | n/a | n/a | -US$83m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$15m | US$574k | -US$108m |
| Sep 30 2021 | n/a | n/a | -US$82m |
| Jun 30 2021 | n/a | n/a | -US$72m |
| Mar 31 2021 | n/a | n/a | -US$63m |
| Dec 31 2020 | US$27m | US$527k | -US$18m |
| Sep 30 2020 | n/a | n/a | -US$25m |
| Jun 30 2020 | n/a | n/a | -US$38m |
| Mar 31 2020 | n/a | n/a | -US$58m |
| Dec 31 2019 | US$254k | US$254k | -US$72m |
Compensation vs Market: Andrew's total compensation ($USD10.82M) is above average for companies of similar size in the US market ($USD6.59M).
Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.
CEO
Andrew Dudum (34 yo)
7.3yrs
Tenure
US$10,816,547
Compensation
Mr. Andrew Dudum serves as Chairman of the Board and serves as Chief Executive Officer at Hims & Hers Health, Inc. since January 20, 2021. He Co-Founded Hims & Hers Health, Inc. in 2017. He is Co-founded H...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 7.3yrs | US$10.82m | 9.22% $ 242.5m | |
| Chief Financial Officer | 2.3yrs | US$7.45m | 0.079% $ 2.1m | |
| Chief Operating Officer | 3.3yrs | US$6.36m | 0.25% $ 6.6m | |
| Senior VP | 4.8yrs | US$961.12k | 0% $ 0 | |
| Chief Legal Officer & Corporate Secretary | 3.3yrs | US$3.96m | 0.077% $ 2.0m | |
| Chief Marketing Officer | 3yrs | US$6.24m | 0.082% $ 2.2m | |
| Chief Medical Officer | 1.3yrs | US$552.02k | 0.086% $ 2.3m | |
| Chief Communications Officer | less than a year | no data | no data | |
| Senior Vice President of Human Resources | 2.1yrs | no data | no data | |
| Senior VP & Member of Medical Advisory Board | no data | no data | no data | |
| Chief Pharmacy & Innovation Officer | 1.3yrs | no data | no data | |
| Senior Vice President of Mental Health | 1.1yrs | no data | no data |
2.3yrs
Average Tenure
42yo
Average Age
Experienced Management: HIMS's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 3.3yrs | US$10.82m | 9.22% $ 242.5m | |
| Chief Medical Officer | 2.2yrs | US$552.02k | 0.086% $ 2.3m | |
| Senior VP & Member of Medical Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | 3.6yrs | US$214.99k | 0.016% $ 425.6k | |
| Independent Director | 3.4yrs | US$224.99k | no data | |
| Independent Director | 3.3yrs | US$222.49k | 0.060% $ 1.6m | |
| Director | less than a year | US$227.49k | 0.033% $ 874.6k | |
| Lead Independent Director | 3.6yrs | US$234.99k | 0.073% $ 1.9m | |
| Independent Director | 3.1yrs | US$215.45k | 0.025% $ 650.6k | |
| Member of Medical Advisory Board | 2.3yrs | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 2.3yrs | no data | no data |
3.1yrs
Average Tenure
50yo
Average Age
Experienced Board: HIMS's board of directors are considered experienced (3.1 years average tenure).